Multiple Sclerosis Nurses at the Limits 2019: Multimedia

Friday 18th & Saturday 19th January 2019

To B or not to B – a definitive guide to B Cells in MS
Professor Gavin Giovannoni
Chair of Neurology, Barts and The London School of Medicine and Dentistry, London, UK


Stem cell therapy in MS – re-booting the immune system to defeat MS
Professor Basil Sharrack
Consultant Neurologist and Honorary Professor of Clinical Neurology, The University of Sheffield, UK


The identification of potential treatment targets in advancing MS
Professor Bruno Stankoff
Professor of Neurology at Pierre and Marie Curie University, Paris, France


Novel Therapeutic approaches to Primary Progressive MS
Dr Eli Silber
Neurology Consultant, King’s College NHS Foundation Trust, London, UK


A review of ongoing trials in SPMS
Dr Jeremy Chataway
UCL Institute of Neurology, London, UK


Living with the App; patient portals & online management of MS
Dr Lorna Paul
Professor of Allied Health Science, School of Health and Life Sciences, Glasgow Caledonian University, Scotland, United Kingdom


Interactions with multiple sclerosis risk genes
Professor Tomas Olsson
Professor/Senior Physician, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden


Lifestyle & environmental factors affecting MS
Dr Trevor Pickersgill
Consultant Neurologist, Cardiff and Vale University Health Board, Wales, UK


A guide to ongoing clinical trials in MS, including new biomarkers
Dr Martin E Duddy
Clinical Director and Consultant Neurologist, The Royal Victoria Infirmary, Newcastle upon Tyne, UK


Should all MS patients be treated with DMTs?
Created by Dr Gordon Mazibrada and Presented in his absence by Dr Trevor Pickersgill & Dr Martin Duddy
Consultant Neurologist Queen Elizabeth Hospital, Birmingham, UK